Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | 0.0058 | 0.9 |
mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | 0.0048 | 0.9 |
mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | -0.0039 | 0.9 |
mRNA | CGP-082996 | GDSC1000 | pan-cancer | AAC | -0.0056 | 0.9 |
mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | -0.0074 | 0.9 |
mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.0056 | 0.9 |
mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | -0.004 | 0.9 |
mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | -0.0034 | 0.9 |
mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | -0.0036 | 0.9 |
mRNA | XL765 | CTRPv2 | pan-cancer | AAC | 0.0038 | 0.9 |